'Blurred lines between war and peace as world resembles pre-WWII era': warns CDS Gen Anil Chauhan Weather alert: Delhi NCR ...

T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells. The modality has remained a big draw for Big Pharma, with Eli Lilly penning ...

Forget hot flashes and period changes. This one overarching issue is the real menace when dealing with perimenopause.

Just outside Minneapolis, the Whipple Building houses offices, a detention center and a courthouse — and has become the home ...

The Trump administration announced Thursday that human fetal tissue derived from abortions can no longer be used in research ...

Discover the challenges of acute myeloid leukaemia linked to inflammatory cell death and the quest for effective therapies.

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. Today, for instance, pharmaceutical companies use ...

Dr. Berenika Maciejewicz, a triple-doctor and an expert in longevity, leads the company’s interdisciplinary team to ...

A molecule produced by cancer cells can shield the brain from Alzheimer’s disease in mice. For decades, researchers have ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

That’s only one problem. Your immune system also has an adaptive system of specialized immune cells and antibodies that attack and destroy invading microbes. This system remembers what those intruders ...